These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9701398)

  • 41. Quantitative nuclear morphometry by image analysis for prediction of recurrence of ductal carcinoma in situ of the breast.
    Hoque A; Lippman SM; Boiko IV; Atkinson EN; Sneige N; Sahin A; Weber DM; Risin S; Lagios MD; Schwarting R; Colburn WJ; Dhingra K; Follen M; Kelloff GJ; Boone CW; Hittelman WN
    Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):249-59. PubMed ID: 11303595
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis of the cellular centrosome in fine-needle aspirations of the breast.
    Guo HQ; Gao M; Ma J; Xiao T; Zhao LL; Gao Y; Pan QJ
    Breast Cancer Res; 2007; 9(4):R48. PubMed ID: 17662154
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intercomparison of apoptosis morphology with active DNA cleavage on single cells in vitro and on testis tumours.
    Abend M; Schmelz HU; Kraft K; Rhein AP; van Beuningen D; Sparwasser C
    J Pathol; 1998 Aug; 185(4):419-26. PubMed ID: 9828842
    [TBL] [Abstract][Full Text] [Related]  

  • 44. DNA cytofluorometry in micro-dissected paraffin embedded breast tissue: description of a method.
    Foschini MP; Ceccarelli C; Chieco P; Lisignoli G; Eusebi V
    Basic Appl Histochem; 1987; 31(4):493-500. PubMed ID: 3442555
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value.
    Spyratos F; Ferrero-Poüs M; Trassard M; Hacène K; Phillips E; Tubiana-Hulin M; Le Doussal V
    Cancer; 2002 Apr; 94(8):2151-9. PubMed ID: 12001111
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Frequency analysis of apoptosis in sporadic breast cancer.
    Kozłowska E; Smolarz B; Kulig A; Romanowicz-Makowska H
    Pol J Pathol; 2006; 57(4):199-204. PubMed ID: 17285763
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ki67 index and S-phase fraction on fine-needle aspirates from breast carcinomas.
    Naldi N; Bozzetti C; Nizzoli R; Camisa R; Guazzi A; Mazzini G
    Eur J Histochem; 1997; 41 Suppl 2():79-80. PubMed ID: 9859793
    [No Abstract]   [Full Text] [Related]  

  • 48. Tissue disaggregation for flow cytometric DNA analysis: comparison of fine-needle aspiration and an automated mechanical procedure.
    Ottesen GL; Christensen IJ; Larsen JK; Hansen B; Andersen JA
    Cytometry; 1996 Mar; 26(1):65-8. PubMed ID: 8809483
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of fixation procedures for fluorescent quantitation of DNA content using image cytometry.
    Maciorowski Z; Veilleux C; Gibaud A; Bourgeois CA; Klijanienko J; Boenders J; Vielh P
    Cytometry; 1997 Jun; 28(2):123-9. PubMed ID: 9181301
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Flow cytometric detection of spontaneous apoptosis in human breast cancer using the TUNEL-technique.
    Ehemann V; Sykora J; Vera-Delgado J; Lange A; Otto HF
    Cancer Lett; 2003 May; 194(1):125-31. PubMed ID: 12706866
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A simple preservative for flow cytometric DNA analysis.
    Alanen KA; Klemi PJ; Taimela S; Joensuu H
    Cytometry; 1989 Jan; 10(1):86-9. PubMed ID: 2917479
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of nuclear grade and DNA cytometry in breast carcinoma aspirates to histologic grade in excised cancers.
    Davey DD; Banks ER; Jennings D; Powell DE
    Am J Clin Pathol; 1993 Jun; 99(6):708-13. PubMed ID: 8322705
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Flow cytometric DNA measurements in aspiration biopsies and surgical specimens of breast cancer.
    Krogerus LA; Railo M; Schoultz M; Nordling S
    Anal Quant Cytol Histol; 1995 Oct; 17(5):309-13. PubMed ID: 8534333
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Flow cytometric DNA analysis using fine needle aspiration sample in breast cancer: preliminary report].
    Andoh Y; Kimijima I; Takita K; Watanabe T; Sekikawa K; Tsuchiya A; Abe R
    Nihon Geka Gakkai Zasshi; 1991 Feb; 92(2):228. PubMed ID: 2038298
    [No Abstract]   [Full Text] [Related]  

  • 55. Fine-needle aspiration and flow cytometry for evaluation of primary breast cancer.
    Hayes DF
    Radiology; 1992 Nov; 185(2):337-8. PubMed ID: 1410333
    [No Abstract]   [Full Text] [Related]  

  • 56. DNA analysis of breast tumour fine needle aspirates using flow cytometry.
    Levack PA; Mullen P; Anderson TJ; Miller WR; Forrest AP
    Br J Cancer; 1987 Nov; 56(5):643-6. PubMed ID: 3426930
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Separation of viable from radiation-induced apoptotic lymphocytes by free-flow electrophoresis.
    Chestkov V; Baibakov B; Radko SP; Chrambach A
    Electrophoresis; 1998 Jun; 19(7):1211-4. PubMed ID: 9662185
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Measurement of apoptotic cells in peripheral blood.
    Carbonari M; Cibati M; Fiorilli M
    Cytometry; 1995 Sep; 22(3):161-7. PubMed ID: 8556946
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Iododeoxyuridine labelling of S-phase fraction in fine needle aspirates from breast carcinomas.
    Maas RA; Bruning PF; Breedijk AJ; Peterse JL
    J Clin Pathol; 1996 Jul; 49(7):607-9. PubMed ID: 8813968
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In situ end labelling of DNA to detect apoptotic cell death in a variety of human tumours.
    Mundle S; Iftikhar A; Shetty V; Alvi S; Dameron S; Gregory S; Marcus B; Khan S; Raza A
    Cell Death Differ; 1994; 1(2):117-22. PubMed ID: 17334328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.